Andrew Lindsley is a Rheumatology/Immunology physician affiliated with Amgen. OpenAlex indexes 105 publications with 2,484 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingNIH funding
1 NIH research award on record, funded 2017–2019 per NIH RePORTER. The latest:
- ORMDL3 Regulation of Dendritic Cells in Asthma
Cincinnati Childrens Hosp Med Ctr
FY2019$187,190K08AI125675 - ORMDL3 Regulation of Dendritic Cells in Asthma
Cincinnati Childrens Hosp Med Ctr
FY2018$188,108K08AI125675 - ORMDL3 Regulation of Dendritic Cells in Asthma
Cincinnati Childrens Hosp Med Ctr
FY2017$189,000K08AI125675
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Kory Lavine, MD
Amgen
Anna Farago, MD, PhD
Amgen
Janet Franklin, MD
Amgen
Siddique Abbasi, MD
Amgen
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”